REG - Societe Generale SA BAWAG Group AG - Form 8.3 - Bawag Group AG
22/04/2026 14:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260422:nRSV5298Ba&default-theme=true
RNS Number : 5298B Societe Generale SA 22 April 2026
Ap27
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH
TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
1. KEY INFORMATION
(a) Full name of discloser SOCIETE GENERALE SA
(b) Owner or controller of interests and short positions disclosed, if BAWAG Group AG
different from 1(a)
The naming of nominee or vehicle companies is insufficient. For a trust, the
trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this
form relates
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state
this and specify identity of offeror/offeree (Note 1)
(e) Date position held/dealing undertaken 21/04/2026
For an opening position disclosure, state the latest practicable date prior to
the disclosure
(f) In addition to the company in 1(c) above, is the discloser also Yes: Permanent TSB Group Holdings plc
making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2
for each additional class of relevant security.
Ap28
Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security €0.01 ordinary shares
(Note 3)
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled 137,175 0.18 56,453 0.07
(2) Cash-settled derivatives 382,847 0.50 341,353 0.44
(3) Stock-settled derivatives (including options) and agreements to 0 0.00 0 0.00
purchase/ sell
Total *787,895 1.02 397,806 0.52
*Include the holding of 267,873 shares on borrow products.
Details of options including rights to subscribe for new securities and any
open stock-settled derivative positions (including traded options), or
agreements to purchase or sell relevant securities, should be given on a
Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE
DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security
securities
EUR (Note 5)
€0.01 ordinary shares Purchase 549 155.1161
€0.01 ordinary shares Purchase 50 153.8
€0.01 ordinary shares Purchase 56 151
€0.01 ordinary shares Purchase 60 151.6
€0.01 ordinary shares Purchase 61 152.1
€0.01 ordinary shares Purchase 64 151.2
€0.01 ordinary shares Purchase 67 153.9
€0.01 ordinary shares Purchase 90 153.8
€0.01 ordinary shares Purchase 25 154.2
€0.01 ordinary shares Purchase 20 148.2
€0.01 ordinary shares Purchase 150 147.8
€0.01 ordinary shares Purchase 100 155
€0.01 ordinary shares Purchase 65 146
€0.01 ordinary shares Purchase 71 146
€0.01 ordinary shares Purchase 4 153.9
€0.01 ordinary shares Purchase 14 153.9
€0.01 ordinary shares Purchase 19 153.9
€0.01 ordinary shares Purchase 19 153.9
€0.01 ordinary shares Purchase 23 154.2
€0.01 ordinary shares Purchase 29 153.9
€0.01 ordinary shares Purchase 32 150.8
€0.01 ordinary shares Purchase 33 153.7
€0.01 ordinary shares Purchase 33 153.9
€0.01 ordinary shares Purchase 33 154
€0.01 ordinary shares Purchase 33 154.5
€0.01 ordinary shares Purchase 33 154.5
€0.01 ordinary shares Purchase 35 152.7
€0.01 ordinary shares Purchase 41 153.2
€0.01 ordinary shares Purchase 41 154.4
€0.01 ordinary shares Purchase 41 154.7
€0.01 ordinary shares Purchase 49 154.5
€0.01 ordinary shares Purchase 52 155.1
€0.01 ordinary shares Purchase 54 154.8
€0.01 ordinary shares Purchase 56 154.9
€0.01 ordinary shares Purchase 58 155.1
€0.01 ordinary shares Purchase 59 151.3
€0.01 ordinary shares Purchase 73 155.2
€0.01 ordinary shares Purchase 20 149.1
€0.01 ordinary shares Purchase 23 152.4
€0.01 ordinary shares Purchase 35 152.7
€0.01 ordinary shares Purchase 36 154.7
€0.01 ordinary shares Purchase 13 153.7
€0.01 ordinary shares Purchase 13 153.8
€0.01 ordinary shares Purchase 14 154.1
€0.01 ordinary shares Purchase 16 153.9
€0.01 ordinary shares Purchase 19 153.2
€0.01 ordinary shares Purchase 20 153.9
€0.01 ordinary shares Purchase 22 153.9
€0.01 ordinary shares Purchase 23 153.3
€0.01 ordinary shares Purchase 25 154.5
€0.01 ordinary shares Purchase 26 149.1
€0.01 ordinary shares Purchase 31 154.5
€0.01 ordinary shares Purchase 38 154.8
€0.01 ordinary shares Purchase 48 154.5
€0.01 ordinary shares Purchase 55 154.9
€0.01 ordinary shares Purchase 56 154.9
€0.01 ordinary shares Purchase 60 155.1
€0.01 ordinary shares Purchase 9 154.4
€0.01 ordinary shares Purchase 20 152.6
€0.01 ordinary shares Purchase 33 154.1
€0.01 ordinary shares Purchase 34 154.4
€0.01 ordinary shares Purchase 37 154
€0.01 ordinary shares Purchase 41 153.2
€0.01 ordinary shares Purchase 20 154.4
€0.01 ordinary shares Purchase 9 155.1
€0.01 ordinary shares Purchase 69 155.3
€0.01 ordinary shares Purchase 89 155.4
€0.01 ordinary shares Purchase 335 154.7
€0.01 ordinary shares Purchase 22 152.9
€0.01 ordinary shares Purchase 65 155.2
€0.01 ordinary shares Purchase 14 151
€0.01 ordinary shares Sale 8,247 154.6835
€0.01 ordinary shares Sale 78 154.6691
€0.01 ordinary shares Sale 490 154.6768
€0.01 ordinary shares Sale 1,733 154.6691
€0.01 ordinary shares Sale 92 154.7
€0.01 ordinary shares Sale 92 154.7
€0.01 ordinary shares Sale 92 154.7
€0.01 ordinary shares Sale 549 155.1161
€0.01 ordinary shares Sale 2 154.5
€0.01 ordinary shares Sale 3 154.5
€0.01 ordinary shares Sale 21 154.6
€0.01 ordinary shares Sale 42 154.6
€0.01 ordinary shares Sale 73 154.6
€0.01 ordinary shares Sale 87 154.6
€0.01 ordinary shares Sale 113 154.9
€0.01 ordinary shares Sale 398 154.7
€0.01 ordinary shares Sale 100 149.4
€0.01 ordinary shares Sale 2 154.4
€0.01 ordinary shares Sale 3 154.5
€0.01 ordinary shares Sale 10 154.5
€0.01 ordinary shares Sale 15 154.4
€0.01 ordinary shares Sale 15 154.5
€0.01 ordinary shares Sale 16 154.4
€0.01 ordinary shares Sale 16 154.6
€0.01 ordinary shares Sale 29 154.6
€0.01 ordinary shares Sale 31 154.6
€0.01 ordinary shares Sale 33 154.4
€0.01 ordinary shares Sale 33 154.4
€0.01 ordinary shares Sale 33 154.5
€0.01 ordinary shares Sale 33 154.6
€0.01 ordinary shares Sale 33 154.6
€0.01 ordinary shares Sale 39 154.9
€0.01 ordinary shares Sale 40 154.6
€0.01 ordinary shares Sale 51 154.9
€0.01 ordinary shares Sale 59 154.6
€0.01 ordinary shares Sale 75 154.6
€0.01 ordinary shares Sale 239 154.9
€0.01 ordinary shares Sale 230 155.2
€0.01 ordinary shares Sale 59 152
€0.01 ordinary shares Sale 7 155
€0.01 ordinary shares Sale 100 148.2
€0.01 ordinary shares Sale 260 151.4
€0.01 ordinary shares Sale 98 154.7
€0.01 ordinary shares Sale 71 153.8
€0.01 ordinary shares Sale 187 154.7
€0.01 ordinary shares Sale 71 153.8
€0.01 ordinary shares Sale 19 147.7
€0.01 ordinary shares Sale 33 152
€0.01 ordinary shares Sale 33 152.1
€0.01 ordinary shares Sale 34 148.4
€0.01 ordinary shares Sale 34 149.3
€0.01 ordinary shares Sale 43 148.8
€0.01 ordinary shares Sale 45 149.2
€0.01 ordinary shares Sale 76 150.9
€0.01 ordinary shares Sale 10 148.4
€0.01 ordinary shares Sale 14 148
€0.01 ordinary shares Sale 14 148
€0.01 ordinary shares Sale 14 148.1
€0.01 ordinary shares Sale 14 148.4
€0.01 ordinary shares Sale 14 149.7
€0.01 ordinary shares Sale 14 150.8
€0.01 ordinary shares Sale 15 148.6
€0.01 ordinary shares Sale 25 148.4
€0.01 ordinary shares Sale 26 151.9
€0.01 ordinary shares Sale 32 149.3
€0.01 ordinary shares Sale 41 148.8
€0.01 ordinary shares Sale 92 154.7
€0.01 ordinary shares Sale 28 150
€0.01 ordinary shares Sale 320 154.7
Ap29
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price
relevant
description
e.g. opening/ closing a long/ short position, increasing/ reducing a long/
reference
per unit EUR
security
e.g. CFD short position
securities
(Note 5)
(Note 6)
€0.01 ordinary shares CFD Increasing a long position 1,733 154.66905943
€0.01 ordinary shares CFD Increasing a long position 490 154.67679592
€0.01 ordinary shares CFD Reducing a short position 78 154.66910256
€0.01 ordinary shares CFD Reducing a short position 8,247 154.68350915
€0.01 ordinary shares Listed Call Warrant Increasing a long position 1.4 77.9
€0.01 ordinary shares Listed Call Warrant Increasing a long position 29 35.6
€0.01 ordinary shares Listed Call Warrant Increasing a long position 26.6 23.9
€0.01 ordinary shares Listed Call Warrant Increasing a long position 18.4 27.6
€0.01 ordinary shares Listed Call Warrant Increasing a long position 8,100 2.7
€0.01 ordinary shares Listed Call Warrant Increasing a long position 720 6.4
€0.01 ordinary shares Listed Call Warrant Increasing a long position 720 6.4
€0.01 ordinary shares Listed Call Warrant Reducing a long position 1.4 75.4
€0.01 ordinary shares Listed Call Warrant Reducing a long position 1 75.7
€0.01 ordinary shares Listed Call Warrant Reducing a long position 5 46
€0.01 ordinary shares Listed Call Warrant Reducing a long position 29 34.3
€0.01 ordinary shares Listed Call Warrant Reducing a long position 52.5 19.1
€0.01 ordinary shares Listed Call Warrant Reducing a long position 620 6.4
€0.01 ordinary shares Listed Call Warrant Reducing a long position 720 6.4
€0.01 ordinary shares Listed Call Warrant Reducing a long position 720 6.4
€0.01 ordinary shares Listed Put Warrant Increasing a short position 100 18.7
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, purchasing, selling, varying Number Exercise Type Expiry Option
relevant description e.g. call etc. of
price per e.g. date money
security option securities unit American,
paid/
to which European received per unit
option
etc.
relates
(Note 6)
(ii) Exercise
Class of Product Exercising/ Number of Exercise
relevant description exercised securities price per
security e.g. call against unit
option (Note 5)
(d) Other dealings (including transactions in respect of
new securities) (Note 3)
Class of Nature of dealing Details Price per unit (if
relevant e.g. subscription, applicable)
security conversion, exercise (Note 5)
Ap30
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to
options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
(c) Attachments
Is a Supplemental Form 8 attached? NO
Date of disclosure 22/04/2026
Contact name Société Générale - Disclosure team
Telephone number +33 1 42 14 92 74
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory
Information Service.
Ap31
NOTES ON FORM 8.3
1. See the definition of "connected fund manager" in
Rule 2.2 of Part A of the Rules.
2. See the definition of "interest in a relevant
security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of
Part B of the Rules.
3. See the definition of "relevant securities" in Rule
2.1 of Part A of the Rules.
4. See the definition of "dealing" in Rule 2.1 of Part
A of the Rules.
5. If the economic exposure to changes in the price of
securities is limited, for example, by virtue of a stop loss arrangement
relating to a spread bet, full details must be given.
6. See Rule 2.5(d) of Part A of the Rules.
7. If details included in a disclosure under Rule 8
are incorrect, they should be corrected as soon as practicable in a subsequent
disclosure. Such disclosure should state clearly that it corrects details
disclosed previously, identify the disclosure or disclosures being corrected,
and provide sufficient detail for the reader to understand the nature of the
corrections. In the case of any doubt, the Panel should be consulted.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act,
1997, Takeover Rules, 2022.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ITPFLFEFSLIFFIR
Copyright 2019 Regulatory News Service, all rights reservedRecent news on BAWAG AG
See all newsREG - T.Rowe Price Assoc BAWAG Group AG - Form 8.3 - BAWAG Group AG
AnnouncementREG - Irish Takeover Panel - Disclosure Table
AnnouncementREG - T.Rowe Price Assoc BAWAG Group AG - Form 8.3 - Bawag Group AG
AnnouncementREG - T.Rowe Price Assoc BAWAG Group AG - Form 8.3 - Bawag Group AG
AnnouncementREG - T.Rowe Price Assoc BAWAG Group AG - Form 8.3 - Bawag Group AG
Announcement